论文部分内容阅读
目的探讨心可舒片联合美托洛尔治疗快速性心律失常(室上性)的临床效果。方法选取天津市红桥区咸阳北路街社区卫生服务中心2013年1-12月来就诊的快速性心律失常患者100例。随机分为两组,各50例。两组常规治疗相同,观察组给予心可舒加美托洛尔。对照组只给美托洛尔。治疗持续6周,并检测记录心电图、24h动态心电图、血脂、肝、肾功能及不良反应发生率等指标。结果观察组的总有效率82.0%,明显高于对照组的70.0%。两组比较差异具有统计学意义(P<0.05)。结论心可舒与美托洛尔联用治疗快速性心律失常比单独使用美托洛尔疗效显著,安全性高,不良反应小。
Objective To investigate the clinical effect of Xinkeshu tablets combined with metoprolol in the treatment of tachyarrhythmia (supraventricular). Methods A total of 100 patients with tachyarrhythmia from January to December 2013 in Xianyang North Road Community Health Service Center of Tianjin were selected. Randomly divided into two groups, 50 cases each. The two groups of conventional treatment the same, the observation group given heart can be metoprolol. The control group only metoprolol. The treatment lasted 6 weeks, and recorded and recorded electrocardiogram, 24h Holter, blood lipids, liver and renal function and the incidence of adverse reactions and other indicators. Results The total effective rate of the observation group was 82.0%, which was significantly higher than that of the control group (70.0%). The difference between the two groups was statistically significant (P <0.05). Conclusions The combination of Xinkushu and metoprolol in the treatment of tachyarrhythmia is more effective than metoprolol alone, with higher safety and less adverse reactions.